Moteur de recherche d’entreprises européennes
Financement de l’UE (5 330 259 €) : Les microalgues en tant que source verte d’ingrédients nutritionnels pour l’alimentation humaine et animale et d’ingrédients pour les cosmétiques grâce à de … Hor 11/05/2017 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Les microalgues en tant que source verte d’ingrédients nutritionnels pour l’alimentation humaine et animale et d’ingrédients pour les cosmétiques grâce à de nouvelles technologies rentables
Today there are only market opportunities for high value applications due to production costs, which are still too high to make microalgae a competitive feedstock for commodities. There is presently a large production capacity for a limited number of microalgae strains in Europe. However, the number of concrete products and market applications is still limited. The enlargement of current market applications for high-value microalgae ingredients will lead to new business opportunities, industrialize the technology and provide the knowledge and experience required to enter the medium- low value market within 5-10 years. MAGNIFICENT will expand the range of commercial products and their market volume substantially and in a sustainable manner. The overall objective of the project is to develop and validate a sustainable and economically feasible new value chain based on cultivation and processing, with the aim to transform microalgae biomass into valuable ingredients for food, aquafeed and cosmetics applications. Development and validation of new product formulations of microalgae are included in the project To achieve this, optimization will be done: 1) Upstream, cultivation related processes via adaptation and selection of algae varieties, improvement of growing conditions and target product concentration in the cell and 2) downstream process steps (separation, extraction, purification) in order to achieve the overall aim to maximise the production of compounds of interest (phospholipids rich in omega-3 fatty acids EPA and DHA and fucoxanthin as main molecules). The work will be supported by chain evaluation, market assessment, socio-economic impact assessment and LCA. Specific attention will be paid to the requirements of the existing EU regulatory framework. The MAGNIFICENT consortium has 16 partners from 7 EU countries incl. 10 SME's, 3 LE's, 1 University and 2 RTO's, and comprises commercial partners in the entire value chain and the 3 target markets.
| Alga Development Engineering And Services SL | 149 986 € |
| Algosource Technologies | 559 579 € |
| Allmicroalgae Natural Products SA | 0,00 € |
| CMP-Cimentos Maceira e Pataias SA | 0,00 € |
| Decerna Ltd. | 199 651 € |
| Erdyn Consultants SAS | 288 125 € |
| Fraunhofer Gesellschaft ZUR Forderung DER Angewandten Forschung e. V. | 387 703 € |
| Imenz Bioengineering B.V. | 232 152 € |
| Kemin Industries | 0,00 € |
| Madebiotech - C R & D SA Zona Franca da Madeira | 476 985 € |
| Natac Biotech SL | 263 125 € |
| Naturextracts sa Zona Franca da Madeira | 0,00 € |
| Necton-Companhia Portuguesa de Culturas Marinhas SA | 771 250 € |
| N-Zyme Biotec GmbH | 0,00 € |
| Sparos Lda. | 403 054 € |
| Stichting Wageningen Research | 221 610 € |
| Totalenergies Raffinage Chimie | 0,00 € |
| Wageningen University | 1 377 040 € |
https://cordis.europa.eu/project/id/745754
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.